SARS-CoV-2 (COVID-19) registry for oncological and hematological patients in Germany
Recruiting
- Conditions
- COVID-19, SARS-CoV-2 infectionMalignant tumorsHematological diseases (MDS, MPS, AA, ITP, PNH)
- Registration Number
- DRKS00023012
- Lead Sponsor
- Arbeitsgemeinschaft der Hämatologen und Onkologen im Krankenhaus e.V. (ADHOK e.V., 1. Vorsitzender) St. Marienkrankenhaus Siegen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 170
Inclusion Criteria
1. Confirmed SARS-CoV-2 infection using PCR
and
2a. the presence of a malignant underlying disease (active or up to a maximum of 5 years ago)
or
2b. the presence any of the following hematological disease: Myelodysplastic Syndrome (MDS), Myeloproliferative Syndrome (MPS), Aplastic Anemia (AA), Immune Thrombocytopenia (ITP), Paroxysmal Nocturnal Hemoglobinuria (PNH)
Exclusion Criteria
None
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Course of SARS-CoV2 infection
- Secondary Outcome Measures
Name Time Method